July 2023

AI studies show value in cardiac CTA | Trifecta heart valve pulled off market | FDA clears AI to guide echo ()
Breaking news: Abbott pulls Trifecta heart valves off the market due to early deterioration ()
Risk of errors during defibrillation leads to a new recall | How depression & cognitive dysfunction impact TAVR ()
Major recalls | Permanent pacemakers after TAVR | Sustainable cath labs | The rise of AI | More from the last week ()
Heart Rhythm Highlights: FDA approves dual-chamber leadless pacemaker | 2 key recalls | AFib after TAVR ()
News Alert: GE Healthcare recalls certain SpO2 sensors due to risk of errors during defibrillation ()
Economics Highlights: An updated look at salaries in cardiology | CMS proposes more Medicare payment cuts ()
Abiomed recalls nearly 8,000 Impella devices | Abbott recalls delivery sheath | A breakthrough at Harvard ()
Breaking News: Nearly 8,000 Impella blood pumps recalled due to risk of injury or death in TAVR patients ()
News Alert: Abbott recalls delivery sheath for LAA occluder device after 16 injuries ()
AFib after TAVR linked to higher risk of death, HF | Exercise & HCM management | Concerns over Medicare cuts ()
ASE 2023: Trends in Amyloid, AI, POCUS and HCM ()
The rise of AI: An update for sonographers | $30M for new PCI & CABG research | PaceMate's new investor ()
New ACC/AHA guidelines on chronic coronary disease | How cath labs can become more sustainable ()
Care Delivery Highlights: Salaries & job satisfaction in cardiology | A key FDA approval | A new drug shortage ()
Permanent pacemakers after TAVR with a self-expanding valve | Immunotherapy for AFib ()
ACC names its next president | 2 significant recalls | CMS proposes more payment cuts | More from the last week ()
Heart Health Highlights: FDA approves first anti-inflammatory drug for CVD | TAVR vs. surgery for obese patients ()
FDA's update after blood test recall | New annuloplasty device for TR shows promise | Cardiac CT & CHD ()
Cardiac Imaging: New videos on amyloidosis & HCM | AI's accurate heart attack assessments | Fetal echo ()
Cardiologists see potential in new TTVR system for TR | Management group acquires 4th Florida practice of 2023 ()
Medtronic recalls implantable devices | TriClip triumphs in real-world setting | ACC's next president, vice president ()
News Alert: Medtronic recalls nearly 350,000 implantable heart devices after 22 injuries ()
Vascular & Endovascular Highlights: Interventional devices recalled | FDA's update on paclitaxel-coated devices ()
Heart attack tests recalled | TAVR vs. surgery among obese patients | New fetal echo guidelines ()
News Alert: FDA announces recall of nearly 8,000 heart attack tests ()
CMS includes more payment cuts in MPFS proposed rule | Eli Lilly to acquire drugmaker for up to $1.9B ()
Salaries & job satisfaction in cardiology | Echocardiography's revival | A new drug shortage | More from the last week ()
News Alert: Eli Lilly to acquire private equity-backed drugmaker for up to $1.9B ()
Keto diet could help heart failure patients | AI model evaluates cardiac function using chest X-rays ()
ASE steps up to provide POCUS training | Tracking outcomes after valve-in-valve TAVR, redo SAVR ()
Interventional Cardiology: More than 250,000 devices recalled | FDA clears new 'grab-and-go' device | IVL for TLE ()
FDA's new stance on paclitaxel-coated devices | Amyloidosis a hot topic in cardiac imaging | Prime energy drinks under fire ()
News Alert: FDA says treating PAD with paclitaxel-coated devices does not increase mortality risk ()
ASE 2023: Key trends in cardiac ultrasound ()
Heart Failure Highlights: FDA's warning about recalled devices | Tracking symptoms after PCI ()
Salaries and job satisfaction in cardiology: 8 key takeaways | Echocardiography's revival | A new drug shortage ()
Small, dissolvable heart monitors could help battle AFib | Trends & technologies at ASE 2023 | HF after PCI ()
New heart valve implanted for first time | Key takeaways from ASE 2023 | TAVR vs. surgery | More from the last week ()
TAVR Highlights: Balloon-expandable vs. self-expandable valves | A historic procedure | Intermediate-risk patients ()
TAVR vs. surgery among intermediate-risk patients | AI helps novice sonographers shine | A question for CMS ()
FDA approves world's first dual-chamber leadless pacemaker | HCM in the spotlight | 'Zero-contrast' TAVR ()
News Alert: FDA approves world’s first dual-chamber leadless pacemaker system ()
June's Top 10 Stories: TAVR controversy | FDA approves colchicine for CVD | Key recalls | Much more! ()
Key takeaways from ASE 2023 | Cardiology groups share a warning | Echo labs not using AI will be left behind ()
A warning: Cardiology societies say affirmative action ruling will do long-term damage to patient care ()